Loading...
Second-Line Irinotecan, Leucovorin, and 5-Fluorouracil for Gastric Cancer Patients after Failed Docetaxel and S-1
Background. This retrospective study aimed to assess the efficacy and toxicities of second-line chemotherapy with irinotecan, leucovorin, and 5-fluorouracil (5-FU) in metastatic gastric cancer (MGC) patients previously treated with docetaxel and S-1 with or without oxaliplatin (DS/DOS). Patients and...
Na minha lista:
| Udgivet i: | Gastroenterol Res Pract |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Hindawi Publishing Corporation
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4709667/ https://ncbi.nlm.nih.gov/pubmed/26839542 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/6857625 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|